Overview

Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.

Status:
Active, not recruiting
Trial end date:
2021-07-31
Target enrollment:
Participant gender:
Summary
Phase IIa, open clinical trial, pilot, single arm and proof of concept.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Treatments:
Dolutegravir
Lamivudine